Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmacilitator is a small private Swedish life sciences consultancy focused on pharmaceutical research and development support rather than proprietary drug commercialization. The company provides consulting, advisory, training, scientific expert input, project management and planning for early drug development through Phase 1, along with medical writing, translation, competitive intelligence, and interim leadership services. Available public records indicate it is an active Swedish aktiebolag founded in 2013 and based in Vallda, Sweden. The business appears to operate as a specialist one-person or very small consultancy led by Stephan Hjorth, with no publicly disclosed internal therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmacilitator.